Skip to main content
Kavita Dhodapkar, MD, Pediatric Hematology & Oncology, Atlanta, GA, Children's Healthcare of Atlanta

KavitaDhodapkarMD

Pediatric Hematology & Oncology Atlanta, GA

Associate Professor, Pediatrics, Yale University School of Medicine

Dr. Dhodapkar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Dhodapkar's full profile

Already have an account?

Education & Training

  • Seth G.S. Medical College
    Seth G.S. Medical CollegeClass of 1991
  • University of Tennessee
    University of TennesseeFellowship, Pediatric Hematology/Oncology

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2018 - 2025
  • CT State Medical License
    CT State Medical License 2008 - 2018
  • NY State Medical License
    NY State Medical License 1998 - 2011
  • AR State Medical License
    AR State Medical License 1995 - 1999
  • MN State Medical License
    MN State Medical License 1993 - 1996
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Specific Components of the Tumor Immune Microenvironment May Affect the Durability of Responses to BCMA CAR T-cell Therapy
    Specific Components of the Tumor Immune Microenvironment May Affect the Durability of Responses to BCMA CAR T-cell TherapyAugust 29th, 2022
  • Immune Cell Changes Detected in Waldenstrom Macroglobulinemia (WM)
    Immune Cell Changes Detected in Waldenstrom Macroglobulinemia (WM)September 2nd, 2021

Grant Support

  • Fcgamma Mediated Regulation Of Dendritic Cell FunctionNational Institute Of Allergy And Infectious Diseases2009–2011
  • Immune Resistance To Glioma VIA Dendritic CellsNational Institute Of Allergy And Infectious Diseases2008
  • Immune Resistance To Glioma VIA Dendritic CellsNational Institute Of Allergy And Infectious Diseases2004–2007
  • Antitumor Immune Response In Patients With Primary Brain TumorsNational Center For Research Resources2005
  • Antitumor Immue Response In Patients With Primary Brain TumorsNational Center For Research Resources2004

Hospital Affiliations